Sickle cell disease trials in Israel

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Enrolling by invitation
  A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

  Where

  Haifa, Safed

  Age

  18 years and over

  People

  55 worldwide

  Run by

  Agios Pharmaceuticals, Inc.

  See details and how to joinNCT05777993 · EU 2026-526243-35-00
• Phase 3Taking people
  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  Where

  Afula, Haifa

  Age

  10 years to 65 years

  People

  192 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06975865
• No phaseTaking people
  Study of the Role of Genetic Modifiers in Hemoglobinopathies

  Where

  Afula

  Age

  2 years and over

  People

  30,000 worldwide

  Run by

  Cyprus Institute of Neurology and Genetics

  See details and how to joinNCT05799118